Abnahme der Vasopressin-Aktivierung nach TIPS-Implantation bei Leberzirrhose
Lukas Hartl(Medical University of Vienna), T Reiberger(Medical University of Vienna), Paul Thöne(Medical University of Vienna), Natalia Dominik(National Hospital for Neurology and Neurosurgery), M Trauner(Medical University of Vienna), M Mandorfer(Medical University of Vienna), Julia Kappel(Medical University of Vienna), Gero Kramer(Memorial Sloan Kettering Cancer Center), M Hintersteininger(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Christian Sebesta(Donauspital), Maria Schoder(Medical University of Vienna), Lukas Reider(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), T Müllner-Bucsics(Medical University of Vienna)
Cited by 0
Related Papers
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
PTA Versus Carbofilm-Coated Stents in Infrapopliteal Arteries: Pilot Study
|CardioVascular and Interventional Radiology|2005|130
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130